CN1131033C - 麻醉制剂 - Google Patents

麻醉制剂 Download PDF

Info

Publication number
CN1131033C
CN1131033C CN98811339A CN98811339A CN1131033C CN 1131033 C CN1131033 C CN 1131033C CN 98811339 A CN98811339 A CN 98811339A CN 98811339 A CN98811339 A CN 98811339A CN 1131033 C CN1131033 C CN 1131033C
Authority
CN
China
Prior art keywords
pharmaceutical composition
sugar
anesthetic
composition according
glucose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CN98811339A
Other languages
English (en)
Chinese (zh)
Other versions
CN1279607A (zh
Inventor
S·布朗
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Darwin Discovery Ltd
Original Assignee
Darwin Discovery Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9724506.2A external-priority patent/GB9724506D0/en
Priority claimed from GBGB9818109.2A external-priority patent/GB9818109D0/en
Application filed by Darwin Discovery Ltd filed Critical Darwin Discovery Ltd
Publication of CN1279607A publication Critical patent/CN1279607A/zh
Application granted granted Critical
Publication of CN1131033C publication Critical patent/CN1131033C/zh
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Anesthesiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
CN98811339A 1997-11-19 1998-11-19 麻醉制剂 Expired - Lifetime CN1131033C (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB9724506.2 1997-11-19
GBGB9724506.2A GB9724506D0 (en) 1997-11-19 1997-11-19 Levobupivacaine and its use
GB9818109.2 1998-08-19
GBGB9818109.2A GB9818109D0 (en) 1998-08-19 1998-08-19 Anaesthetic Formulation

Publications (2)

Publication Number Publication Date
CN1279607A CN1279607A (zh) 2001-01-10
CN1131033C true CN1131033C (zh) 2003-12-17

Family

ID=26312628

Family Applications (1)

Application Number Title Priority Date Filing Date
CN98811339A Expired - Lifetime CN1131033C (zh) 1997-11-19 1998-11-19 麻醉制剂

Country Status (17)

Country Link
US (1) US5932597A (enExample)
EP (1) EP1032390B1 (enExample)
JP (1) JP2001522888A (enExample)
KR (1) KR100695588B1 (enExample)
CN (1) CN1131033C (enExample)
AT (1) ATE253913T1 (enExample)
AU (1) AU740914B2 (enExample)
BR (1) BR9814883A (enExample)
CA (1) CA2308495C (enExample)
DE (1) DE69819770T2 (enExample)
DK (1) DK1032390T3 (enExample)
ES (1) ES2209217T3 (enExample)
HU (1) HU228143B1 (enExample)
IL (1) IL135922A0 (enExample)
NO (1) NO328684B1 (enExample)
PT (1) PT1032390E (enExample)
WO (1) WO1999025349A1 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9824161D0 (en) * 1998-11-04 1998-12-30 Darwin Discovery Ltd Drug formulation
US20040001889A1 (en) 2002-06-25 2004-01-01 Guohua Chen Short duration depot formulations
SI1575569T1 (sl) 2002-12-13 2010-12-31 Durect Corp Oralni sistem dostave zdravila, ki obsega visokoviskozne tekoče nosilne materiale
SI2767292T1 (sl) 2004-09-17 2017-01-31 Durect Corporation Pripravek, ki vsebuje lokalni anestetik SAIB, s podaljšanim sproščanjem
US20060270708A1 (en) * 2005-05-25 2006-11-30 Navinta Llc Novel process for preparation of isotonic aqueous injection of ropivacaine
US20070027105A1 (en) 2005-07-26 2007-02-01 Alza Corporation Peroxide removal from drug delivery vehicle
EP2117521B1 (en) 2006-11-03 2012-06-27 Durect Corporation Transdermal delivery systems comprising bupivacaine
EP2067471B1 (en) * 2007-12-06 2018-02-14 Durect Corporation Oral pharmaceutical dosage forms
US20100260844A1 (en) 2008-11-03 2010-10-14 Scicinski Jan J Oral pharmaceutical dosage forms
SG11201407323WA (en) * 2012-05-10 2014-12-30 Cellix Bio Private Ltd Compositions and methods for the treatment of local pain
CA2905131A1 (en) 2013-03-15 2014-09-18 Durect Corporation Compositions with a rheological modifier to reduce dissolution variability
EP3331508B1 (en) * 2015-07-13 2024-08-14 Neon Laboratories Ltd. Hyperbaric solution injection of levobupivacaine hydrochloride comprising levobupivacaine hydrochloride
JP7258561B2 (ja) 2016-07-06 2023-04-17 オリエント ファーマ シーオー．，エルティーディー． 薬物組成物、バリヤー層及び薬物層を有している経口投与形態
KR20220140711A (ko) 2020-01-13 2022-10-18 듀렉트 코퍼레이션 불순물이 감소된 지속 방출 약물 전달 시스템 및 관련 방법
KR20230145053A (ko) 2021-01-12 2023-10-17 듀렉트 코퍼레이션 지속 방출 약물 전달 시스템 및 관련 방법
WO2025175174A1 (en) * 2024-02-14 2025-08-21 The Children's Medical Center Corporation 2'-6'-pipecoloxylidide as a sensory-selective anesthetic

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990000390A1 (en) * 1988-07-08 1990-01-25 Aktiebolaget Astra New synergistic preparations containing dezocine and a local anaesthetic and a new method of alleviation of pain

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9321061D0 (en) * 1993-10-13 1993-12-01 Chiroscience Ltd Analgestic agent and its use
EP0727210B1 (en) * 1993-10-13 2001-12-19 Darwin Discovery Limited Analgesic agent and its use

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990000390A1 (en) * 1988-07-08 1990-01-25 Aktiebolaget Astra New synergistic preparations containing dezocine and a local anaesthetic and a new method of alleviation of pain

Also Published As

Publication number Publication date
CA2308495C (en) 2009-01-06
AU1168499A (en) 1999-06-07
HUP0004665A2 (hu) 2001-04-28
WO1999025349A1 (en) 1999-05-27
CA2308495A1 (en) 1999-05-27
NO20002545L (no) 2000-05-18
KR20010032241A (ko) 2001-04-16
BR9814883A (pt) 2000-10-03
EP1032390B1 (en) 2003-11-12
AU740914B2 (en) 2001-11-15
JP2001522888A (ja) 2001-11-20
ATE253913T1 (de) 2003-11-15
DK1032390T3 (da) 2004-03-15
DE69819770T2 (de) 2004-09-23
HK1026848A1 (en) 2000-12-29
DE69819770D1 (de) 2003-12-18
NO328684B1 (no) 2010-04-26
CN1279607A (zh) 2001-01-10
NO20002545D0 (no) 2000-05-18
PT1032390E (pt) 2004-04-30
KR100695588B1 (ko) 2007-03-14
EP1032390A1 (en) 2000-09-06
HUP0004665A3 (en) 2004-05-28
HU228143B1 (en) 2012-12-28
US5932597A (en) 1999-08-03
IL135922A0 (en) 2001-05-20
ES2209217T3 (es) 2004-06-16

Similar Documents

Publication Publication Date Title
CN1131033C (zh) 麻醉制剂
US12310930B2 (en) Stabilization of epinephrine formulations
EP1553953B1 (en) Method and composition containing latanoprost for treating ocular hypertension and glaucoma
US12083087B2 (en) Aqueous formulation comprising paracetamol and ibuprofen
BG65304B1 (bg) Воден състав, съдържащ моксифлоксацин и натриев хлорид
KR20170123724A (ko) 저 투여량의 디클로페낙 및 베타-사이클로덱스트린 제형
EP3687475A1 (en) Stabilization of epinephrine formulations
HUP0204520A2 (en) Pharmaceutical composition containing esmolol and process for its preparation
CN102264346A (zh) 用于通过颊透粘膜途径来施用降血脂药的制剂
PT90356B (pt) Processo para a preparacao de composicoes farmaceuticas contendo solucoes aquosas de pentamidina
EP1293206A1 (en) Water-based liquid preparation
US7008934B2 (en) Composition and method for reducing adverse interactions between phenothiazine derivatives and plasma using cyclodextrins
JPH06509801A (ja) カルバコールおよびその他のコリン作動性物質を含有する薬学的組成物
CA2010085C (en) Pentamidine solutions
CN1835758A (zh) 高浓度甘草甜素制剂
HK1026848B (en) Anaesthetic formulation
JP7534129B2 (ja) 多成分配合点眼剤
CA2621015C (en) New use for a composition comprising chloroprocaine hcl, a new composition comprising chloroprocaine hcl and a method for its manufacture
JP2004269363A (ja) アセトアミノフェンを含有する安定な水性医薬組成物
MXPA00004746A (en) Anaesthetic formulation
JP7160799B2 (ja) タペンタドールの非経口投与用安定製剤
US5997884A (en) Compositions and method for treating migraine
JP2009526819A (ja) 塩酸プリロカインを有する新規の高比重組成物、この新規の組成物の髄腔内麻酔への使用、及びこの組成物の製造方法

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CX01 Expiry of patent term
CX01 Expiry of patent term

Granted publication date: 20031217